Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Apr;27(4):523–526. doi: 10.1111/j.1365-2125.1989.tb05403.x

Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.

G E McVeigh 1, E B Dulie 1, A Ravenscroft 1, D B Galloway 1, G D Johnston 1
PMCID: PMC1379734  PMID: 2655692

Abstract

In a double-blind, placebo controlled, randomised parallel study we investigated the antihypertensive activity and metabolic adverse effects of three doses of cyclopenthiazide in 53 patients with mild hypertension. After a 4 week placebo washout period, patients with diastolic blood pressures between 90-110 mm Hg were randomly assigned to receive 50 micrograms, 125 micrograms and 500 micrograms of cyclopenthiazide or matching placebo, over an 8 week active treatment period. Blood pressure was recorded at 2 weekly intervals during the trial. Venous samples were taken for evaluation of drug effect on indices of carbohydrate and lipid metabolism just prior to, and on completion of, the active treatment period. Systolic and diastolic blood pressure decreased significantly (P less than 0.05) with the 125 micrograms and 500 micrograms doses of cyclopenthiazide. No change was apparent in any index of glucose and lipid metabolism over time. Low and conventional doses of cyclopenthiazide lower blood pressure without alteration to the metabolic profile in the short term.

Full text

PDF
523

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Berthaux P., Bulpitt C., Deruyttere M., de Schaepdryver A., Dollery C., Fagard R., Forette F., Hellemans J., Lund-Johansen P. Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet. 1978 Apr 1;1(8066):681–683. doi: 10.1016/s0140-6736(78)90797-3. [DOI] [PubMed] [Google Scholar]
  2. Ames R. P., Hill P. Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy. Circulation. 1982 May;65(5):899–904. doi: 10.1161/01.cir.65.5.899. [DOI] [PubMed] [Google Scholar]
  3. Beling S., Vukovich R. A., Neiss E. S., Zisblatt M., Webb E., Losi M. Long-term experience with indapamide. Am Heart J. 1983 Jul;106(1 Pt 2):258–262. doi: 10.1016/0002-8703(83)90126-6. [DOI] [PubMed] [Google Scholar]
  4. Crisp A. J., Kennedy P. G., Hoffbrand B. I., Ebbutt A. F., Carruthers M. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. Curr Med Res Opin. 1980;7(2):101–103. doi: 10.1185/03007998009112034. [DOI] [PubMed] [Google Scholar]
  5. Furman B. L. Impairment of glucose tolerance produced by diuretics and other drugs. Pharmacol Ther. 1981;12(3):613–649. doi: 10.1016/0163-7258(81)90102-9. [DOI] [PubMed] [Google Scholar]
  6. Grimm R. H., Jr, Leon A. S., Hunninghake D. B., Lenz K., Hannan P., Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med. 1981 Jan;94(1):7–11. doi: 10.7326/0003-4819-94-1-7. [DOI] [PubMed] [Google Scholar]
  7. Helgeland A., Strømmen R., Hagelund C. H., Tretli S. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway. Lancet. 1986 Apr 19;1(8486):872–875. doi: 10.1016/s0140-6736(86)90985-2. [DOI] [PubMed] [Google Scholar]
  8. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  9. Kannel W. B., Gordon T., Schwartz M. J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol. 1971 Apr;27(4):335–346. doi: 10.1016/0002-9149(71)90428-0. [DOI] [PubMed] [Google Scholar]
  10. McVeigh G., Galloway D., Johnston D. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. BMJ. 1988 Jul 9;297(6641):95–98. doi: 10.1136/bmj.297.6641.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Perez-Stable E., Caralis P. V. Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism. Am Heart J. 1983 Jul;106(1 Pt 2):245–251. doi: 10.1016/0002-8703(83)90124-2. [DOI] [PubMed] [Google Scholar]
  12. Weinberger M. H. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. Arch Intern Med. 1985 Jun;145(6):1102–1105. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES